Yahoo Finance 3 Marijuana Stocks Canadian Investors Are Talking About
CORAL GABLES, FL / ACCESSWIRE / August 14, 2018 / This year, Canada is expected to see a big boom come this October with the launch of its adult-use, recreational market. This change comes after the country's Senate passed the Cannabis Act, also known as Bill C-45, and because of it, October will be accompanied by a little more than the usual pumpkin carvings and cavity-inciting endeavors. Investors are on the edge of their seats trying to figure out which industry leaders will come out on top of the market that is set to launch on October 17.
Market analysts have projected that Canada's legalized market could earn somewhere around $10.4 billion dollars once it gets started. Big paydays like this make investments opportunities in this innovative industry all the more exciting. Companies like GTEC Holdings, Ltd, (GTEC)(GGTTF), Canopy Growth (NYSE: CGC; TSX: WEED), and CV Sciences (CVSI) have caught attention during the months leading up to Canada's official launch for recreational retail sales.
GTEC Holdings, Ltd, (GTEC)(GGTTF) signed an LOI with TheraProducts to create a joint venture to develop and commercialize cannabis-based beverages and edibles.
GTEC will contribute its OLEO microencapsulation technology to convert cannabis oils to soluble powder, and TheraProducts will supply equipment and intellectual property.
Under the terms of the Letter of Intent, both parties will work towards finalizing a Definitive Agreement on or before September 1st, 2018. Financial terms of the arrangement have not been disclosed.
GTEC is currently focused on growing premium quality craft cannabis in purpose-built indoor facilities. The company currently holds a 100% interest in GreenTec Bio-Pharmaceuticals Corp., Tumbleweed Farms Corp., Falcon Ridge Naturals Ltd., Alberta Craft Cannabis Inc., Grey Bruce Farms Inc., Zenalytic Laboratories Ltd. and Spectre Labs Inc.
For More information On GTEC Holdings, Click Here
CV Sciences (CVSI) has come into the public's microscope after it announced that it had appointed Joseph Maroon, MD, FACS to its Board of Directors. The Nevada-based company operates two distinct business segments: a drug development division focused on developing and commercializing novel therapeutics utilizing synthetic CBD, and a consumer product division focused on manufacturing, marketing and selling plant-based CBD products to a range of market sectors.
Dr. Maroon has been a team neurosurgeon in the National Football League since 1981 and serves as medical director of other professional sports organizations. He has served on the editorial boards of eight medical and neurological journals and is currently associate editor of Surgical Neurology and editorial board member of Neurological Research and The Physician and Sports Medicine journals.
Shares of CV Sciences are up over 700% this year, to date.
For More Information On CV Sciences, Click Here
Today, shares of Canopy Growth (NYSE: CGC; TSX: WEED) stumbled a bit during the early morning session. The company will be reporting earnings ahead of a paramount move for the country of Canada in a few months. This morning the company announced that it has issued $2,500,000 in common shares of Canopy Growth in connection with the expansion of an existing commercial arrangement.
Canopy Growth is a diversified cannabis and hemp company, offering distinct brands and curated cannabis varieties in dried, oil and Softgel capsule forms. From product and process innovation to market execution, Canopy Growth is driven by a passion for leadership and a commitment to building a world-class cannabis company one product, site and country at a time.
For More Information On Canopy Growth, Click Here
About marijuanastocks.com
MarijuanaStocks.com is the leading web destination for all things cannabis. Investors can find marijuana-related financial, medical, legal, and social news anytime day or night. Writers are invited to submit cannabis related articles for publication.
Legal Disclaimer
Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. MAPH Enterprises LLC which owns www.MarijuanaStocks.com is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release.
MAPH Enterprises LLC, which owns www.MarijuanaStocks.com, may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice. MAPH Enterprises LLC, which owns www.MarijuanaStocks.com, may be compensated for its services in the form of cash-based compensation or equity securities in the companies it writes about, or a combination of the two. Pursuant to an agreement between an affiliate of MAPH Enterprises, LLC, Midam Ventures LLC and GTEC Holdings Inc., Midam is being paid $63,333 per month from the company for a total of 12 months and has received ZERO shares of GTEC Holdings Inc. for a duration of beginning July 10, 2018 and ending July 10, 2019. We may buy or sell additional shares of (GTEC) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information.
Contact Information:
SOURCE: MarijuanaStocks.com
